Symbol
TRVI on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership
1.27M shares
Security Ownership
1.4%

Venrock Healthcare Capital Partners II, L.P. ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)

2025-02-14 - Venrock Healthcare Capital Partners II, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.27M shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI). This represents 1.4% percent ownership of the company.